Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.100
-0.010 (-0.24%)
At close: Mar 28, 2025, 4:00 PM
3.910
-0.190 (-4.64%)
Pre-market: Mar 31, 2025, 8:48 AM EDT

Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $136.11 million. The enterprise value is $24.51 million.

Market Cap 136.11M
Enterprise Value 24.51M

Important Dates

The last earnings date was Monday, March 24, 2025, before market open.

Earnings Date Mar 24, 2025
Ex-Dividend Date n/a

Share Statistics

LXEO has 33.20 million shares outstanding. The number of shares has increased by 493.67% in one year.

Current Share Class 33.20M
Shares Outstanding 33.20M
Shares Change (YoY) +493.67%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 4.46%
Owned by Institutions (%) 79.61%
Float 21.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.16
P/TBV Ratio 1.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.08.

Current Ratio 5.52
Quick Ratio 5.32
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -772.01

Financial Efficiency

Return on equity (ROE) is -85.37% and return on invested capital (ROIC) is -52.48%.

Return on Equity (ROE) -85.37%
Return on Assets (ROA) -46.11%
Return on Invested Capital (ROIC) -52.48%
Return on Capital Employed (ROCE) -85.23%
Revenue Per Employee n/a
Profits Per Employee -$1.37M
Employee Count 72
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.15% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -73.15%
50-Day Moving Average 4.06
200-Day Moving Average 8.72
Relative Strength Index (RSI) 57.61
Average Volume (20 Days) 931,307

Short Selling Information

The latest short interest is 2.22 million, so 6.67% of the outstanding shares have been sold short.

Short Interest 2.22M
Short Previous Month 2.43M
Short % of Shares Out 6.67%
Short % of Float 10.16%
Short Ratio (days to cover) 4.47

Income Statement

Revenue n/a
Gross Profit -74.09M
Operating Income -105.77M
Pretax Income -69.42M
Net Income -98.33M
EBITDA -105.14M
EBIT -105.77M
Earnings Per Share (EPS) -$3.09
Full Income Statement

Balance Sheet

The company has $121.52 million in cash and $9.92 million in debt, giving a net cash position of $111.59 million or $3.36 per share.

Cash & Cash Equivalents 121.52M
Total Debt 9.92M
Net Cash 111.59M
Net Cash Per Share $3.36
Equity (Book Value) 116.84M
Book Value Per Share 3.53
Working Capital 103.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.15 million and capital expenditures -$481,000, giving a free cash flow of -$81.63 million.

Operating Cash Flow -81.15M
Capital Expenditures -481,000
Free Cash Flow -81.63M
FCF Per Share -$2.46
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -493.67%
Shareholder Yield n/a
Earnings Yield -72.25%
FCF Yield -59.98%

Analyst Forecast

The average price target for LXEO is $22.80, which is 456.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.80
Price Target Difference 456.10%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 4.39%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1